# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001125345-23-000067
Filing Date
2023-04-17
Accepted
2023-04-17 16:01:50
Documents
5
Period of Report
2023-05-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | def_14ax2023.htm | DEF 14A | 940198
2 |  | chart-97fafa9e4528415a85d.jpg | GRAPHIC | 115294
3 |  | image.jpg | GRAPHIC | 7365
4 |  | mgnx_proxyxcardxpagex1.jpg | GRAPHIC | 675168
5 |  | mgnx_proxyxcardxpagex2.jpg | GRAPHIC | 179286
| Complete submission text file | 0001125345-23-000067.txt |  | 2287216

Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36112 | Film No.: 23823936
SIC: 2834 Pharmaceutical Preparations